Abstract:Go proteins are among the most abundant proteins in the brain. Here we show that knockout of Gao1 affects the development of the hippocampal mossy fiber tract (MFT), a pivotal part of the information flow through this brain area. Gao1−/− mice exhibit reduced synaptic termination fields of the MFT and an altered course of the infrapyramidal bundle (IPB) as part of the MFT. In line with this, cultured Gao1‐depleted neurons show a reduced process outgrowth. Double knockout of Gao1 and Gao2 largely rescues these effects. Single knockout of Gαo2 does not affect MFT morphology besides being known to enhance process outgrowth of cultured neurons. The heterotrimeric G‐protein αo subunit is ubiquitously expressed in the CNS as two splice variants Gαo1 and Gαo2, regulating various brain functions. Here, we investigated the effect of single Gαo1, Gαo2, and double Gαo1/2 knockout on the postnatal development of the murine mossy fiber tract, a central pathway of the hippocampal connectivity circuit. The size of the hippocampal synaptic termination fields covered by mossy fiber boutons together with various fiber length parameters of the tract was analyzed by immunohistochemical staining of the vesicular Zinc transporter 3 (ZnT3) or Synaptoporin at postnatal days 2, 4, 8, 12, 16, and in the adult. Ultimately, Gαo1 knockout resulted in a reduced developmental growth of synaptic mossy fiber terminal fields by 37% in the adult Stratum lucidum and by 30% in the total mossy fiber tract size. Other morphological parameters such as projection length of the infrapyramidal bundle of the tract were increased (+52% in Gαo1−/− mice). In contrast, Gαo2 knockout had no effects on the mossy fiber tract. Moreover, by using primary heterozygous and homozygous Gαo1 knockout hippocampal cultures, we detected a strongly pronounced reduction in axon and dendrite length (−50% and −38%, respectively) as well as axon and dendrite arborization complexity (−75% and −72% branch nodes, respectively) in the homozygous knockout. Deletion of both splice variants Gαo1 and Gαo2 partially rescued the in vivo and completely reconstituted the in vitro effects, indicating an opposing functional relevance of the two Gαo splice variants for neuronal development and synaptic connectivity.

Gnao1 is a molecular switch that regulates the Rho signaling pathway in differentiating neurons

Genetic modeling of GNAO1 disorder delineates mechanisms of Go dysfunction

Cortical neurons obtained from patient-derived iPSCs with GNAO1 p.G203R variant show altered differentiation and functional properties

Gαo is a major determinant of cAMP signaling in the pathophysiology of movement disorders.

AAV9-Mediated Intrastriatal Delivery of GNAO1 Reduces Hyperlocomotion in Gnao1 Heterozygous R209H Mutant Mice

GNAO1 Mutations Affecting the N‐Terminal α‐Helix of Gαo Lead to Parkinsonism

The Schwann cell-specific G-protein Gαo (Gnao1) is a cell-intrinsic controller contributing to the regulation of myelination in peripheral nerve system

RNA Interference Effectors Selectively Silence the Pathogenic Variant GNAO1 c.607 G > A In Vitro

GNAO1 Overexpression Promotes Neural Differentiation of Glioma Stem-Like Cells and Reduces Tumorigenicity Through TRIM21/CREB/HES1 Axis

Phenotypes of GNAO1 Variants in a Chinese Cohort

NRSF- GNAO1 Pathway Contributes to the Regulation of Cardiac Ca2+ Homeostasis

CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the Gnao1 for safety studies of RNA therapeutics

Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy.

Gαo1 and Gαo1/Gαo2 deletion differentially affect hippocampal mossy fiber tract anatomy and neuronal morphogenesis

Novel GNE missense variants impair de novo sialylation and cause defective angiogenesis in the developing brain in mice

De Novo Variants in AGO1 Recapitulate a Heterogeneous Neurodevelopmental Disorder Phenotype

Neuron specific quantitation of Gαolf expression and signaling in murine brain tissue

Zinc for GNAO1 encephalopathy: Preclinical profiling and a clinical case

The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors

Molecular Dynamic Simulations to Determine Individualized Therapy: Tetrabenazine for the GNAO1 Encephalopathy E246K Variant

Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA Methylation